+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Gender-related significance of time interval between radiotherapy and surgery in hypofractionated preoperative radiotherapy for rectal cancer patients' survival



Gender-related significance of time interval between radiotherapy and surgery in hypofractionated preoperative radiotherapy for rectal cancer patients' survival



Reports of Practical Oncology and RadioTherapy 21(3): 174-180



An optimal break between radiotherapy (RT) and surgery in short-course of RT (SCRT) for locally advanced rectal cancer is not clearly established. The aim of the study was to investigate the influence of the break in the preoperative SCRT and overall treatment time (OTT) for locally advanced rectal cancer patients (whole group and male/female subgroups) on patients overall survival (OS), recurrence-free survival (RFS), metastasis-free survival (MFS). 131 patients were treated with SCRT (5 Gy/5 days), followed by surgery 3-53 days later. Break was calculated as the time interval between the end of irradiation to surgery and OTT as time interval from the beginning of RT to surgery. Mean break was 21.5 (range 3-53.0) days and mean OTT was 26.5 (range 7-58.0) days. In univariate analysis, a break longer than 15 days and OTT >23 days were negative prognostic factors for OS for all patients, and particularly for the male patients' subgroup. RFS was non-significantly higher (P = 0.066) for patients treated with a break ≤15 days and OTT ≤23 days (P = 0.099), irrespectively of patients' sex. Patients treated with a break longer than 15 days and OTT >23 days had non-significantly lower level of MFS than those treated with a shorter break (P = 0.269) and OTT ≤23 days (P = 0.498). In SCRT, a break in the treatment longer than 15 days, especially in the male patients subgroup, should be avoided, because it negatively affects patients' survival.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057922537

Download citation: RISBibTeXText

PMID: 27601947

DOI: 10.1016/j.rpor.2016.01.004


Related references

Gender-related prognostic significance of clinical and biological tumor features in rectal cancer patients receiving short-course preoperative radiotherapy. Reports of Practical Oncology and RadioTherapy 22(5): 368-377, 2017

Interval between preoperative radiotherapy and surgery influences postoperative mortality in rectal cancer patients The sooner the better. European Journal of Cancer 37(Suppl. 6): S273, 2001

Effect of time interval between capecitabine intake and radiotherapy on local recurrence-free survival in preoperative chemoradiation for locally advanced rectal cancer. Radiation Oncology Journal 35(2): 129-136, 2017

Pathological insights of radiotherapy-related damage to surgical margin after preoperative radiotherapy in patients with rectal cancer. Zhonghua Wai Ke Za Zhi 55(7): 507-514, 2017

Gender-related differences in repopulation and early tumor response to preoperative radiotherapy in rectal cancer patients. Journal of Gastrointestinal Surgery 15(9): 1568-1576, 2011

Significance of an exon 2 G4C14-to-A4T14 polymorphism in the p73 gene on survival in rectal cancer patients with or without preoperative radiotherapy. RadioTherapy and Oncology 92(2): 215-220, 2009

PINCH is an independent prognostic factor in rectal cancer patients without preoperative radiotherapy--a study in a Swedish rectal cancer trial of preoperative radiotherapy. Bmc Cancer 12: 65, 2012

Meta-analysis of preoperative radiotherapy for resectable rectal cancer: improvement of overall survival rate, tumor-specific survival rate and local recurrence control by preoperative radiotherapy. Strahlentherapie und Onkologie 177(12): 681-682, 2001

An observational study of extending FOLFOX chemotherapy, lengthening the interval between radiotherapy and surgery, and enhancing pathological complete response rates in rectal cancer patients following preoperative chemoradiotherapy. Therapeutic Advances in Gastroenterology 9(5): 702-712, 2016

Optimal time interval between capecitabine intake and radiotherapy in preoperative chemoradiation for locally advanced rectal cancer. International Journal of Radiation Oncology Biology Physics 67(4): 1020-1026, 2007

Gender-related differences in pathological and clinical tumor response based on immunohistochemical proteins expression in rectal cancer patients treated with short course of preoperative radiotherapy. Journal of Gastrointestinal Surgery 18(7): 1306-1318, 2014

KRAS Mutation Status Is Not a Predictor for Tumor Response and Survival in Rectal Cancer Patients Who Received Preoperative Radiotherapy With 5-Fluoropyrimidine Followed by Curative Surgery. Medicine 94(31): E1284, 2015

Adjuvant Chemotherapy Seemed Not to Have Survival Benefit in Rectal Cancer Patients with ypTis-2N0 After Preoperative Radiotherapy and Surgery from a Population-Based Propensity Score Analysis. Oncologist 24(6): 803-811, 2019

Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancer. Colorectal Disease 8(5): 430-435, 2006

Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group. European Journal of Cancer 40(2): 219-224, 2004